# FDA recall D-0703-2018

> **AuroMedics Pharma LLC** · Class II · drug recall initiated 2018-03-27.

## Product

Linezolid Injection 600 mg per 300 mL (2 mg/mL) For Intravenous Administration, Rx only, Manufactured By: Aurobindo Pharma Limited IDA Pashamylaram - 502307, India, Manufactured for AuroMedics Pharma, LLC, NDC 55150-242-51

## Reason for recall

Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap

## Distribution

US Nationwide

## Key facts

- **Recall number:** D-0703-2018
- **Recalling firm:** AuroMedics Pharma LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-03-27
- **Report date:** 2018-05-09
- **Termination date:** 2022-02-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Windsor, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0703-2018

## Citation

> AI Analytics. FDA recall D-0703-2018. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0703-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*